Despite the considerable attention HIF‐1α has attracted as a target for revascularization in peripheral ischemic tissues, there is a limited knowledge on the effects of HIF‐1α‐based therapies in atherosclerotic cardiovascular diseases in aging. Here, HIF1A is linked to cardiovascular disorder.